Xian Li, Yun Liang, Wenbin Qian, Yaping Xie, Wenping Wu, Ying Lu. "Efficacy, safety, and genetic analysis of orelabrutinib combined with rituximab as first-line systemic treatment for marginal zone lymphoma.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.7059